Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Hip Reconstruction or Hip Replacement is an intervention which involves replacement of the damaged or diseased parts of the hip joint. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hip reconstruction devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hip reconstruction market in the UK was Zimmer Biomet followed by DePuy Synthes, Stryker, Smith & Nephew, Medacta Group, Corin Group, Limacorporate, Exactech, United Orthopedic, MicroPort Scientific and B. Braun Melsungen.
The Hip Reconstruction includes devices (implants) used in the hip replacement interventions. A Hip Replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. Modern artificial hip joints are generally designed to last for 15 years or more.
The value of the hip reconstruction devices market within the UK was expected to be over $200m in 2023.
For the latest complete market share analysis of hip reconstruction device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
